Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease-Reference-Cited by-同舟云学术

Comparison of Human and Experimental Pulmonary Veno-Occlusive Disease

Published:2020-07 Issue:1 Volume:63 Page:118-131
ISSN:1044-1549
Container-title:American Journal of Respiratory Cell and Molecular Biology
language:en
Short-container-title:Am J Respir Cell Mol Biol

Author:

Manaud Grégoire¹²³,Nossent Esther J.⁴,Lambert Mélanie¹²³,Ghigna Maria-Rosa⁵^ORCID,Boët Angèle⁶,Vinhas Maria-Candida⁶,Ranchoux Benoit¹²³,Dumas Sébastien J.¹²³,Courboulin Audrey¹²³,Girerd Barbara¹²³,Soubrier Florent⁷,Bignard Juliette⁷,Claude Olivier⁷^ORCID,Lecerf Florence¹²³,Hautefort Aurélie¹²³,Florio Monica⁸,Sun Banghua⁸,Nadaud Sophie⁷^ORCID,Verleden Stijn E.⁹,Remy Séverine¹⁰,Anegon Ignacio¹⁰,Bogaard Harm Jan⁴,Mercier Olaf¹²³¹¹,Fadel Elie¹²³¹¹,Simonneau Gérald¹²³,Vonk Noordegraaf Anton⁴,Grünberg Katrien⁴,Humbert Marc¹²³^ORCID,Montani David¹²³^ORCID,Dorfmüller Peter¹²³⁵¹²,Antigny Fabrice¹²³^ORCID,Perros Frédéric¹²³^ORCID

Affiliation:

1. Université Paris-Saclay–Faculté de Médecine, Le Kremlin-Bicêtre, France

2. AP-HP, Centre de Référence de l’Hypertension Pulmonaire, Service de Pneumologie et Réanimation Respiratoire, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France

3. UMRS 999, INSERM and Université Paris-Saclay, Laboratoire d’Excellence en Recherche sur le Médicament et l’Innovation Thérapeutique, and

4. Amsterdam UMC, Vrije Universiteit Amsterdam, Pulmonary Medicine, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands

5. Department of Pathology and

6. Department of Research, Hôpital Marie Lannelongue, Le Plessis-Robinson, France

7. INSERM UMR_S 956, Pierre and Marie Curie Université (Paris 06), Paris, France

8. Cardio-Metabolic Disorders, Amgen Research, Amgen Inc., Thousand Oaks, California

9. Laboratory of Respiratory Diseases and Thoracic Surgery, Department of Chronic Diseases, Metabolism and Ageing KU Leuven, Leuven, Belgium

10. INSERM UMR 1064, Center for Research in Transplantation and Immunology-ITUN et Transgenic Rats and Immunophenomic Platform, Nantes, France; and

11. Service de Chirurgie Thoracique, Hôpital Marie Lannelongue, Le Plessis Robinson, France

12. Department of Pathology, University of Giessen and Marburg Lung Center, Justus-Liebig University Giessen, German Center for Lung Research, Giessen, Germany

Publisher

American Thoracic Society

Subject

Cell Biology,Clinical Biochemistry,Pulmonary and Respiratory Medicine,Molecular Biology

Reference54 articles.

1. Pulmonary veno-occlusive disease

2. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study

3. EIF2AK4 mutations cause pulmonary veno-occlusive disease, a recessive form of pulmonary hypertension

4. Pulmonary veno-occlusive disease as an occupational lung disease

5. The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. General control nonderepressible 2 (GCN2) as a therapeutic target in age-related diseases;Frontiers in Aging;2024-09-10

2. Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response;Nature Cardiovascular Research;2024-07-09

3. Risk Assessment in Pulmonary Veno-Occlusive Disease: The First Step Towards Future Trials?;Archivos de Bronconeumología;2024-07

4. Novel insights into the GCN2 pathway and its targeting. Therapeutic value in cancer and lessons from lung fibrosis development;The FEBS Journal;2024-06-16

5. Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors;European Respiratory Journal;2024-05-02